{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:51:52Z","timestamp":1762480312930,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaesthesia Critical Care &amp; Pain Medicine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.accpm.2021.101011","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T02:16:39Z","timestamp":1639620999000},"page":"101011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacodynamics of rocuronium in sickle cell patients"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1609-9298","authenticated-orcid":false,"given":"Dominique","family":"Djomo Tamchom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basile","family":"Essola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristide","family":"Kuitchet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Ndikontar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Nga Nomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Benghiat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panayota","family":"Kapessidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Baurain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0040-2558","authenticated-orcid":false,"given":"Luc","family":"Van Obbergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.accpm.2021.101011_bib0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/ijns4040037","article-title":"Neonatal screening for sickle cell disease in Belgium for more than 20 years: an experience for comprehensive care improvement","volume":"4","author":"Gulbis","year":"2018","journal-title":"IJNS"},{"key":"10.1016\/j.accpm.2021.101011_bib0010","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/00000658-198804000-00011","article-title":"Assessment of the use of transfusion therapy perioperatively in patients with sickle cell hemoglobinopathies","volume":"207","author":"Bischoff","year":"1988","journal-title":"Ann Surg"},{"key":"10.1016\/j.accpm.2021.101011_bib0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.14423\/SMJ.0000000000000524","article-title":"Perioperative management in sickle cell disease","volume":"109","author":"Paschal","year":"2016","journal-title":"South Med J"},{"key":"10.1016\/j.accpm.2021.101011_bib0020","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1213\/ane.0b013e318176be1f","article-title":"The onset time of atracurium is prolonged in patients with sickle cell disease","volume":"107","author":"Dulvadestin","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.accpm.2021.101011_bib0025","article-title":"Definitions of the phenotypic manifestations of sickle cell disease","author":"Ballas","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.accpm.2021.101011_bib0030","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.revmed.2011.03.117","article-title":"La formule CPK-EPI est la meilleure m\u00e9thode pour estimer le d\u00e9bit de filtration glom\u00e9rulaire chez les patients dr\u00e9panocytaires adultes","volume":"32","author":"Arlet","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.accpm.2021.101011_bib0035","first-page":"7","article-title":"Monitoring of neuromuscular block","volume":"6","author":"McGrath","year":"2006","journal-title":"Contin Educ Anaesth Crit Care Pain"},{"key":"10.1016\/j.accpm.2021.101011_bib0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1399-6576.1996.tb04389.x","article-title":"Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents","volume":"40","author":"Viby-Mogensen","year":"1996","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.accpm.2021.101011_bib0045","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1399-6576.2007.01352.x","article-title":"Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision","volume":"51","author":"Fuchs\u2010Buder","year":"2007","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.accpm.2021.101011_bib0050","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2165\/00003088-199631030-00002","article-title":"Clinical pharmacokinetics of rocuronium bromide","volume":"31","author":"Khuenl-Brady","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.accpm.2021.101011_bib0055","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/bja\/85.5.717","article-title":"Urinary, biliary and faecal excretion of rocuronium in humans","volume":"85","author":"Proost","year":"2000","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.accpm.2021.101011_bib0060","first-page":"861","article-title":"The influence of acute normovolemic hemodilution on the dose-response and time course of action of vecuronium","volume":"86","author":"Xue","year":"1998","journal-title":"Anesth Analg"},{"key":"10.1016\/j.accpm.2021.101011_bib0065","doi-asserted-by":"crossref","first-page":"273","DOI":"10.17085\/apm.2016.11.3.273","article-title":"Influence of acute normovolemic hemodilution on the potency and time course of action of rocuronium in rabbits","volume":"11","author":"Lee","year":"2016","journal-title":"Anesth Pain Med"},{"key":"10.1016\/j.accpm.2021.101011_bib0070","first-page":"848","article-title":"The onset of rocuronium, but not of vecuronium or mivacurium, is modified by tourniquet inflation","volume":"82","author":"Audibert","year":"1996","journal-title":"Anesth Analg"},{"key":"10.1016\/j.accpm.2021.101011_bib0075","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1213\/00000539-199805000-00049","article-title":"Cardiac output and onset time of different muscle relaxants","volume":"86","author":"Simhi","year":"1998","journal-title":"Anesth Analg"},{"key":"10.1016\/j.accpm.2021.101011_bib0080","doi-asserted-by":"crossref","first-page":"500","DOI":"10.4097\/kjae.2017.70.5.500","article-title":"Factors that affect the onset of action of non-depolarizing neuromuscular blocking agents","volume":"70","author":"Kim","year":"2017","journal-title":"Korean J Anesthesiol"},{"key":"10.1016\/j.accpm.2021.101011_bib0085","doi-asserted-by":"crossref","first-page":"889","DOI":"10.14740\/jocmr3137w","article-title":"The sixth vital sign: body mass index in patients with sickle cell disease","volume":"9","author":"Ballas","year":"2017","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.accpm.2021.101011_bib0090","article-title":"Nutritional status of children and adolescents with sickle cell disease","volume":"4","author":"Samara Agda dos","year":"2018","journal-title":"J Nutr Med Diet Care"},{"key":"10.1016\/j.accpm.2021.101011_bib0095","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/0310057X9802600409","article-title":"Effect of nutritional status on vecuronium induced neuromuscular blockade","volume":"26","author":"Sinha","year":"1998","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.accpm.2021.101011_bib0100","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1007\/s12630-013-9914-x","article-title":"In non-obese patients, duration of action of rocuronium is directly correlated with body mass index","volume":"60","author":"Fujimoto","year":"2013","journal-title":"Can J Anesth"},{"key":"10.1016\/j.accpm.2021.101011_bib0105","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1213\/00000539-199411000-00032","article-title":"Anthropometric variables as predictors for duration of action of vecuronium-induced neuromuscular block","volume":"79","author":"Kirkegaard-Nielsen","year":"1994","journal-title":"Anesth Analg"},{"key":"10.1016\/j.accpm.2021.101011_bib0110","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jpeds.2017.12.021","article-title":"Association between oxidative stress, genetic factors, and clinical severity in children with sickle cell Anemia","volume":"195","author":"Renoux","year":"2018","journal-title":"J Pediatr"},{"key":"10.1016\/j.accpm.2021.101011_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10245332.2018.1498441","article-title":"Oxidative stress, antioxidant capacity, biomolecule damage, and inflammation symptoms of sickle cell disease in children","volume":"24","author":"Biswal","year":"2019","journal-title":"Hematology"},{"key":"10.1016\/j.accpm.2021.101011_bib0120","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/ajh.22012","article-title":"Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management","volume":"86","author":"Nur","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.accpm.2021.101011_bib0125","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1182\/blood.V96.1.314","article-title":"Reperfusion injury pathophysiology in sickle transgenic mice","volume":"96","author":"Osarogiagbon","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.accpm.2021.101011_bib0130","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1007\/BF03026928","article-title":"Onset of action of relaxants","volume":"35","author":"Donati","year":"1988","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.accpm.2021.101011_bib0135","series-title":"Chronic kidney disease and sickle cell disease. Chronic renal disease","first-page":"513","author":"Pham","year":"2015"},{"key":"10.1016\/j.accpm.2021.101011_bib0140","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrneph.2015.8","article-title":"Sickle cell disease: renal manifestations and mechanisms","volume":"11","author":"Nath","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.accpm.2021.101011_bib0145","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1096-8652(200004)63:4<205::AID-AJH8>3.0.CO;2-8","article-title":"Renal abnormalities in sickle cell disease","volume":"63","author":"Ataga","year":"2000","journal-title":"Am J Haematol"},{"key":"10.1016\/j.accpm.2021.101011_bib0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/bja\/aeh181","article-title":"Physicochemical properties of neuromuscular blocking agents and their impact on the pharmacokinetic\u2013pharmacodynamic relationship","volume":"93","author":"Roy","year":"2004","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.accpm.2021.101011_bib0155","first-page":"2","article-title":"Pharmacology of neuromuscular blocking drugs","volume":"4","author":"Appiah-Ankam","year":"2004","journal-title":"Contin Educ Anaesth Crit Care Pain"}],"container-title":["Anaesthesia Critical Care &amp; Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352556821002186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352556821002186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:48:06Z","timestamp":1762480086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352556821002186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2352556821002186"],"URL":"https:\/\/doi.org\/10.1016\/j.accpm.2021.101011","relation":{},"ISSN":["2352-5568"],"issn-type":[{"type":"print","value":"2352-5568"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacodynamics of rocuronium in sickle cell patients","name":"articletitle","label":"Article Title"},{"value":"Anaesthesia Critical Care & Pain Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.accpm.2021.101011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise d'anesth\u00e9sie et de r\u00e9animation (Sfar).","name":"copyright","label":"Copyright"}],"article-number":"101011"}}